Microvascular effects of vasoactive agents in shock.
D000368:Aged; D000804:Angiotensin II / Q000494:pharmacology; D000818:Animals; D001158:Arteries / Q000187:drug effects; D001769:Blood; D001808:Blood Vessels / Q000187:drug effects*; D002610:Cheek; D006224:Cricetinae; D004837:Epinephrine / Q000494:pharmacology; D005260:Female; D006801:Humans; D009638:Norepinephrine / Q000494:pharmacology; D010643:Phenoxybenzamine / Q000494:pharmacology; D010646:Phentolamine / Q000494:pharmacology; D010949:Plasma; D012769:Shock / Q000097:blood*; D014662:Vasoconstrictor Agents / Q000494:pharmacology; D014680:Veins / Q000187:drug effects
D014662:Vasoconstrictor Agents; D010643:Phenoxybenzamine; D000804:Angiotensin II; D009638:Norepinephrine; D004837:Epinephrine; D010646:Phentolamine